Skip to main content

Lactiplantibacillus plantarum 299v (LP299V®): three decades of research.

  • 2021-10-11
  • Beneficial Microbes 12(5)
    • E. Nordström
    • C. Teixeira
    • C. Montelius
    • B. Jeppsson
    • N. Larsson

Abstract

This review aims to provide a comprehensive overview of the in vitro, animal, and clinical studies with the bacterial strain Lactiplantibacillus plantarum 299v (L. plantarum 299v; formerly named Lactobacillus plantarum 299v) published up until June 30, 2020. L. plantarum 299v is the most documented L. plantarum strain in the world, described in over 170 scientific publications out of which more than 60 are human clinical studies. The genome sequence of L. plantarum 299v has been determined and is available in the public domain (GenBank Accession number: NZ_LEAV01000004). The probiotic strain L. plantarum 299v was isolated from healthy human intestinal mucosa three decades ago by scientists at Lund University, Sweden. Thirty years later, a wealth of data coming from in vitro, animal, and clinical studies exist, showing benefits primarily for gastrointestinal health, such as reduced flatulence and abdominal pain in patients with irritable bowel syndrome (IBS). Moreover, several clinical studies have shown positive effects of L. plantarum 299v on iron absorption and more recently also on iron status. L. plantarum 299v is safe for human consumption and does not confer antibiotic resistance. It survives the harsh conditions of the human gastrointestinal tract, adheres to mannose residues on the intestinal epithelial cells and has in some cases been re-isolated more than ten days after administration ceased. Besides studying health benefits, research groups around the globe have investigated L. plantarum 299v in a range of applications and processes. L. plantarum 299v is used in many different food applications as well as in various dietary supplements. In a freeze-dried format, L. plantarum 299v is robust and stable at room temperature, enabling long shelf-lives of consumer healthcare products such as capsules, tablets, or powder sachets. The strain is patent protected for a wide range of indications and applications worldwide as well as trademarked as LP299V®.

Keywords: digestive health; iron absorption; irritable bowel syndrome; probiotic.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactiplantibacillus plantarumImproved Iron AbsorptionBeneficial
Moderate
Lactiplantibacillus plantarumImproved Iron LevelsBeneficial
Moderate
Lactiplantibacillus plantarumReduced Abdominal PainBeneficial
Moderate
Lactiplantibacillus plantarumReduced FlatulenceBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Improved Iron AbsorptionBeneficial
Moderate
Lactobacillus plantarum 299vImproved Iron LevelsBeneficial
Moderate
Lactobacillus plantarum 299vReduced Abdominal PainBeneficial
Moderate
Lactobacillus plantarum 299vReduced FlatulenceBeneficial
Moderate
Lactobacillus plantarum LP-01Improved Iron AbsorptionBeneficial
Moderate
Lactobacillus plantarum LP-01Improved Iron LevelsBeneficial
Moderate
Lactobacillus plantarum LP-01Reduced Abdominal PainBeneficial
Moderate
Lactobacillus plantarum LP-01Reduced FlatulenceBeneficial
Moderate
Lactobacillus plantarum LP09Improved Iron AbsorptionBeneficial
Moderate
Lactobacillus plantarum Lp-115Reduced Abdominal PainBeneficial
Moderate
Lactobacillus plantarum Lp-115Reduced FlatulenceBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.